 | • レポートコード：MRC2102QY16215 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のワルデンシュトレームマクログロブリン血症（WM）治療市場について種類別（CB-839、塩酸コパンリシブ、DI-B4、エントスプレチニブ、エベロリムス、FV-162、その他）、用途別（クリニック、病院、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ワルデンシュトレームマクログロブリン血症（WM）治療市場の概要 ・世界の主要地域別ワルデンシュトレームマクログロブリン血症（WM）治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のワルデンシュトレームマクログロブリン血症（WM）治療市場規模2015-2026：種類別（CB-839、塩酸コパンリシブ、DI-B4、エントスプレチニブ、エベロリムス、FV-162、その他） ・世界のワルデンシュトレームマクログロブリン血症（WM）治療市場規模2015-2026：用途別（クリニック、病院、その他） ・ワルデンシュトレームマクログロブリン血症（WM）治療の米国市場規模2015-2020 ・ワルデンシュトレームマクログロブリン血症（WM）治療のヨーロッパ市場規模2015-2020 ・ワルデンシュトレームマクログロブリン血症（WM）治療の中国市場規模2015-2020 ・ワルデンシュトレームマクログロブリン血症（WM）治療の日本市場規模2015-2020 ・ワルデンシュトレームマクログロブリン血症（WM）治療の東南アジア市場規模2015-2020 ・ワルデンシュトレームマクログロブリン血症（WM）治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ワルデンシュトレームマクログロブリン血症（WM）治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ワルデンシュトレームマクログロブリン血症（WM）治療の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Waldenstrom Macroglobulinemia Therapeutics Market
The global Waldenstrom Macroglobulinemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Waldenstrom Macroglobulinemia Therapeutics Scope and Market Size
The global Waldenstrom Macroglobulinemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Waldenstrom Macroglobulinemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Waldenstrom Macroglobulinemia Therapeutics market is segmented into
CB-839
Copanlisib Hydrochloride
DI-B4
Entospletinib
Everolimus
FV-162
Others
Segment by Application, the Waldenstrom Macroglobulinemia Therapeutics market is segmented into
Clinic
Hospital
Others
The Waldenstrom Macroglobulinemia Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Waldenstrom Macroglobulinemia Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Waldenstrom Macroglobulinemia Therapeutics Market Share Analysis
Waldenstrom Macroglobulinemia Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Waldenstrom Macroglobulinemia Therapeutics business, the date to enter into the Waldenstrom Macroglobulinemia Therapeutics market, Waldenstrom Macroglobulinemia Therapeutics product introduction, recent developments, etc.
The major vendors covered:
BeiGene (Beijing) Co.,Ltd
Calithera Biosciences, Inc.
Celgene Corporation
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
Hutchison MediPharma Limited
Idera Pharmaceuticals, Inc.
IGF Oncology, LLC.
Incyte Corporation
Karyopharm Therapeutics, Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.
1 Waldenstrom Macroglobulinemia Therapeutics Market Overview
1.1 Waldenstrom Macroglobulinemia Therapeutics Product Scope
1.2 Waldenstrom Macroglobulinemia Therapeutics Segment by Type
1.2.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales by Type (2020-2026)
1.2.2 CB-839
1.2.3 Copanlisib Hydrochloride
1.2.4 DI-B4
1.2.5 Entospletinib
1.2.6 Everolimus
1.2.7 FV-162
1.2.8 Others
1.3 Waldenstrom Macroglobulinemia Therapeutics Segment by Application
1.3.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Waldenstrom Macroglobulinemia Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Waldenstrom Macroglobulinemia Therapeutics Price Trends (2015-2026)
2 Waldenstrom Macroglobulinemia Therapeutics Estimate and Forecast by Region
2.1 Global Waldenstrom Macroglobulinemia Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Waldenstrom Macroglobulinemia Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Waldenstrom Macroglobulinemia Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Waldenstrom Macroglobulinemia Therapeutics Estimates and Projections (2015-2026)
3 Global Waldenstrom Macroglobulinemia Therapeutics Competition Landscape by Players
3.1 Global Top Waldenstrom Macroglobulinemia Therapeutics Players by Sales (2015-2020)
3.2 Global Top Waldenstrom Macroglobulinemia Therapeutics Players by Revenue (2015-2020)
3.3 Global Waldenstrom Macroglobulinemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Waldenstrom Macroglobulinemia Therapeutics as of 2019)
3.4 Global Waldenstrom Macroglobulinemia Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Waldenstrom Macroglobulinemia Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Waldenstrom Macroglobulinemia Therapeutics Players (Opinion Leaders)
4 Global Waldenstrom Macroglobulinemia Therapeutics Market Size by Type
4.1 Global Waldenstrom Macroglobulinemia Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Waldenstrom Macroglobulinemia Therapeutics Price by Type (2015-2020)
4.2 Global Waldenstrom Macroglobulinemia Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Waldenstrom Macroglobulinemia Therapeutics Price Forecast by Type (2021-2026)
5 Global Waldenstrom Macroglobulinemia Therapeutics Market Size by Application
5.1 Global Waldenstrom Macroglobulinemia Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Waldenstrom Macroglobulinemia Therapeutics Price by Application (2015-2020)
5.2 Global Waldenstrom Macroglobulinemia Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Waldenstrom Macroglobulinemia Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Waldenstrom Macroglobulinemia Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Waldenstrom Macroglobulinemia Therapeutics Price Forecast by Application (2021-2026)
6 United States Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
6.1 United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
6.2 United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
6.3 United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
7 Europe Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
7.1 Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
7.2 Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
7.3 Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
8 China Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
8.1 China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
8.2 China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
8.3 China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
9 Japan Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
9.1 Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (3015-3030)
9.2 Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
9.3 Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
10 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
10.1 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
11 India Waldenstrom Macroglobulinemia Therapeutics Market Facts & Figures
11.1 India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
11.2 India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
11.3 India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Waldenstrom Macroglobulinemia Therapeutics Business
12.1 BeiGene (Beijing) Co.,Ltd
12.1.1 BeiGene (Beijing) Co.,Ltd Corporation Information
12.1.2 BeiGene (Beijing) Co.,Ltd Business Overview
12.1.3 BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.1.5 BeiGene (Beijing) Co.,Ltd Recent Development
12.2 Calithera Biosciences, Inc.
12.2.1 Calithera Biosciences, Inc. Corporation Information
12.2.2 Calithera Biosciences, Inc. Business Overview
12.2.3 Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.2.5 Calithera Biosciences, Inc. Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Corporation Information
12.3.2 Celgene Corporation Business Overview
12.3.3 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.3.5 Celgene Corporation Recent Development
12.4 Genentech, Inc.
12.4.1 Genentech, Inc. Corporation Information
12.4.2 Genentech, Inc. Business Overview
12.4.3 Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.4.5 Genentech, Inc. Recent Development
12.5 Genmab A/S
12.5.1 Genmab A/S Corporation Information
12.5.2 Genmab A/S Business Overview
12.5.3 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.5.5 Genmab A/S Recent Development
12.6 Gilead Sciences, Inc.
12.6.1 Gilead Sciences, Inc. Corporation Information
12.6.2 Gilead Sciences, Inc. Business Overview
12.6.3 Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.6.5 Gilead Sciences, Inc. Recent Development
12.7 Hutchison MediPharma Limited
12.7.1 Hutchison MediPharma Limited Corporation Information
12.7.2 Hutchison MediPharma Limited Business Overview
12.7.3 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.7.5 Hutchison MediPharma Limited Recent Development
12.8 Idera Pharmaceuticals, Inc.
12.8.1 Idera Pharmaceuticals, Inc. Corporation Information
12.8.2 Idera Pharmaceuticals, Inc. Business Overview
12.8.3 Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.8.5 Idera Pharmaceuticals, Inc. Recent Development
12.9 IGF Oncology, LLC.
12.9.1 IGF Oncology, LLC. Corporation Information
12.9.2 IGF Oncology, LLC. Business Overview
12.9.3 IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.9.5 IGF Oncology, LLC. Recent Development
12.10 Incyte Corporation
12.10.1 Incyte Corporation Corporation Information
12.10.2 Incyte Corporation Business Overview
12.10.3 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.10.5 Incyte Corporation Recent Development
12.11 Karyopharm Therapeutics, Inc.
12.11.1 Karyopharm Therapeutics, Inc. Corporation Information
12.11.2 Karyopharm Therapeutics, Inc. Business Overview
12.11.3 Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.11.5 Karyopharm Therapeutics, Inc. Recent Development
12.12 Merck KGaA
12.12.1 Merck KGaA Corporation Information
12.12.2 Merck KGaA Business Overview
12.12.3 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.12.5 Merck KGaA Recent Development
12.13 Millennium Pharmaceuticals, Inc.
12.13.1 Millennium Pharmaceuticals, Inc. Corporation Information
12.13.2 Millennium Pharmaceuticals, Inc. Business Overview
12.13.3 Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Products Offered
12.13.5 Millennium Pharmaceuticals, Inc. Recent Development
13 Waldenstrom Macroglobulinemia Therapeutics Manufacturing Cost Analysis
13.1 Waldenstrom Macroglobulinemia Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Waldenstrom Macroglobulinemia Therapeutics
13.4 Waldenstrom Macroglobulinemia Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Waldenstrom Macroglobulinemia Therapeutics Distributors List
14.3 Waldenstrom Macroglobulinemia Therapeutics Customers
15 Market Dynamics
15.1 Waldenstrom Macroglobulinemia Therapeutics Market Trends
15.2 Waldenstrom Macroglobulinemia Therapeutics Opportunities and Drivers
15.3 Waldenstrom Macroglobulinemia Therapeutics Market Challenges
15.4 Waldenstrom Macroglobulinemia Therapeutics Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Waldenstrom Macroglobulinemia Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Region (2015-2020)
Table 5. Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Region (2015-2020)
Table 6. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Region (2015-2020)
Table 8. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Waldenstrom Macroglobulinemia Therapeutics (K Pcs) of Key Companies (2015-2020)
Table 13. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Company (2015-2020)
Table 14. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Company (2015-2020)
Table 16. Global Waldenstrom Macroglobulinemia Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Waldenstrom Macroglobulinemia Therapeutics as of 2019)
Table 17. Global Waldenstrom Macroglobulinemia Therapeutics Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Waldenstrom Macroglobulinemia Therapeutics Manufacturing Sites and Area Served
Table 19. Manufacturers Waldenstrom Macroglobulinemia Therapeutics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Waldenstrom Macroglobulinemia Therapeutics Players
Table 22. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 23. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Waldenstrom Macroglobulinemia Therapeutics Price (K Pcs) by Type (2015-2020)
Table 26. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Type (2021-2026)
Table 27. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Type (2021-2026)
Table 29. Global Waldenstrom Macroglobulinemia Therapeutics Price (K Pcs) by Type (2021-2026)
Table 30. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 31. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Application (2015-2020)
Table 32. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Waldenstrom Macroglobulinemia Therapeutics Price (K Pcs) by Application (2015-2020)
Table 34. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2021-2026)
Table 35. Global Waldenstrom Macroglobulinemia Therapeutics Sales Share by Application (2021-2026)
Table 36. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Application (2021-2026)
Table 38. Global Waldenstrom Macroglobulinemia Therapeutics Price (K Pcs) by Application (2021-2026)
Table 39. United States Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 40. United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 41. United States Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 42. United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 43. United States Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 44. United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Europe Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 47. Europe Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 49. Europe Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 51. China Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 52. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 53. China Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 54. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 55. China Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 56. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Japan Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 59. Japan Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Japan Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
Table 69. India Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Company (2015-2020)
Table 70. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company (2015-2020)
Table 71. India Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Type (2015-2020)
Table 72. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type (2015-2020)
Table 73. India Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) by Application (2015-2020)
Table 74. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application (2015-2020)
Table 75. BeiGene (Beijing) Co.,Ltd Corporation Information
Table 76. BeiGene (Beijing) Co.,Ltd Description and Business Overview
Table 77. BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. BeiGene (Beijing) Co.,Ltd Waldenstrom Macroglobulinemia Therapeutics Product
Table 79. BeiGene (Beijing) Co.,Ltd Recent Development
Table 80. Calithera Biosciences, Inc. Corporation Information
Table 81. Calithera Biosciences, Inc. Description and Business Overview
Table 82. Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Calithera Biosciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 84. Calithera Biosciences, Inc. Recent Development
Table 85. Celgene Corporation Corporation Information
Table 86. Celgene Corporation Description and Business Overview
Table 87. Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Celgene Corporation Waldenstrom Macroglobulinemia Therapeutics Product
Table 89. Celgene Corporation Recent Development
Table 90. Genentech, Inc. Corporation Information
Table 91. Genentech, Inc. Description and Business Overview
Table 92. Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Genentech, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 94. Genentech, Inc. Recent Development
Table 95. Genmab A/S Corporation Information
Table 96. Genmab A/S Description and Business Overview
Table 97. Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Genmab A/S Waldenstrom Macroglobulinemia Therapeutics Product
Table 99. Genmab A/S Recent Development
Table 100. Gilead Sciences, Inc. Corporation Information
Table 101. Gilead Sciences, Inc. Description and Business Overview
Table 102. Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Gilead Sciences, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 104. Gilead Sciences, Inc. Recent Development
Table 105. Hutchison MediPharma Limited Corporation Information
Table 106. Hutchison MediPharma Limited Description and Business Overview
Table 107. Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Hutchison MediPharma Limited Waldenstrom Macroglobulinemia Therapeutics Product
Table 109. Hutchison MediPharma Limited Recent Development
Table 110. Idera Pharmaceuticals, Inc. Corporation Information
Table 111. Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Idera Pharmaceuticals, Inc. Description and Business Overview
Table 113. Idera Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 114. Idera Pharmaceuticals, Inc. Recent Development
Table 115. IGF Oncology, LLC. Corporation Information
Table 116. IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. IGF Oncology, LLC. Description and Business Overview
Table 118. IGF Oncology, LLC. Waldenstrom Macroglobulinemia Therapeutics Product
Table 119. IGF Oncology, LLC. Recent Development
Table 120. Incyte Corporation Corporation Information
Table 121. Incyte Corporation Description and Business Overview
Table 122. Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Incyte Corporation Waldenstrom Macroglobulinemia Therapeutics Product
Table 124. Incyte Corporation Recent Development
Table 125. Karyopharm Therapeutics, Inc. Corporation Information
Table 126. Karyopharm Therapeutics, Inc. Description and Business Overview
Table 127. Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Karyopharm Therapeutics, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 129. Karyopharm Therapeutics, Inc. Recent Development
Table 130. Merck KGaA Corporation Information
Table 131. Merck KGaA Description and Business Overview
Table 132. Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Merck KGaA Waldenstrom Macroglobulinemia Therapeutics Product
Table 134. Merck KGaA Recent Development
Table 135. Millennium Pharmaceuticals, Inc. Corporation Information
Table 136. Millennium Pharmaceuticals, Inc. Description and Business Overview
Table 137. Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Millennium Pharmaceuticals, Inc. Waldenstrom Macroglobulinemia Therapeutics Product
Table 139. Millennium Pharmaceuticals, Inc. Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Waldenstrom Macroglobulinemia Therapeutics Distributors List
Table 143. Waldenstrom Macroglobulinemia Therapeutics Customers List
Table 144. Waldenstrom Macroglobulinemia Therapeutics Market Key Trends
Table 145. Waldenstrom Macroglobulinemia Therapeutics Key Opportunities and Drivers
Table 146. Waldenstrom Macroglobulinemia Therapeutics Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Waldenstrom Macroglobulinemia Therapeutics Product Picture
Figure 2. Global Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Waldenstrom Macroglobulinemia Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Waldenstrom Macroglobulinemia Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Waldenstrom Macroglobulinemia Therapeutics Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Waldenstrom Macroglobulinemia Therapeutics Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Waldenstrom Macroglobulinemia Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Waldenstrom Macroglobulinemia Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Waldenstrom Macroglobulinemia Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Waldenstrom Macroglobulinemia Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Waldenstrom Macroglobulinemia Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Waldenstrom Macroglobulinemia Therapeutics Players Market Share by Revenue in Waldenstrom Macroglobulinemia Therapeutics 2015 & 2019
Figure 27. Waldenstrom Macroglobulinemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Type (2015-2020)
Figure 29. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Share by Application (2015-2020)
Figure 31. Global Waldenstrom Macroglobulinemia Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 33. United States Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 34. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company in 2019
Figure 35. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 36. Europe Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application in 2019
Figure 37. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company in 2019
Figure 38. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 39. China Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application in 2019
Figure 40. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company in 2019
Figure 41. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 42. Japan Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application in 2019
Figure 43. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company in 2019
Figure 44. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 45. Southeast Asia Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application in 2019
Figure 46. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Company in 2019
Figure 47. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Type in 2019
Figure 48. India Waldenstrom Macroglobulinemia Therapeutics Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Waldenstrom Macroglobulinemia Therapeutics
Figure 51. Manufacturing Process Analysis of Waldenstrom Macroglobulinemia Therapeutics
Figure 52. Waldenstrom Macroglobulinemia Therapeutics Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
旅行者用下痢治療薬の世界市場レポート2020 Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. M…- 泌尿器がん治療薬の世界市場レポート2020 Global Urological Cancer Therapeutics Drugs Market is estimated to reach $48.6 billion by 2025 Says, .Now a days urological cancers became very common worldwide and causing higher mortality rates. Specially in the case of kidney cancers, that illustrates the new therapeutic targets. Urological cance…
- 乳がん治療薬の世界市場レポート2020 Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) for postmenopausal women. Side effects can include hot flashes and vaginal dryness Market Analysis and Insights: Global…
- ヒストンデアセチラーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Histone Deacetylase Inhibitors Market The global Histone Deacetylase Inhibitors market size is projected to reach US$ 2043.7 million by 2026, from US$ 1028 million in 2020, at a CAGR of 12.1% during 2021-2026. Global Histone Deacetylase Inhibitors Scope and Marke…
- 細胞性腫瘍抗体P53の世界市場レポート2020 Market Analysis and Insights: Global Cellular Tumor Antigen p53 Market The global Cellular Tumor Antigen p53 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cellular Tumor Antigen p53 Scope and Market Size The global Ce…